Metformin as a senostatic drug enhances the anticancer efficacy of CDK4/6 inhibitor in head and neck squamous cell carcinoma
Qinchao Hu(Sun Yat-sen University), Tong Wu(Stomatology Hospital)
Cited by 71
Related Papers
Modulation of IL-1β reprogrammes the tumor microenvironment to interrupt oral carcinogenesis
|Scientific Reports|2016|69
The poor outcome of second primary oral squamous cell carcinoma is attributed to Bmi1 upregulation
|Cancer Medicine|2018|22
Sulfasalazine combined with anti-IL-1β mAb induces ferroptosis and immune modulation in oral squamous cell carcinoma
|Cellular and Molecular Life Sciences|2025|8